에 대한 최신 뉴스 Pharmaron Beijing Co (OTC:PHBBF) 주식

Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.

News

Politics

Markets

PHBBF

WUXAY

WXXWY

도널드 트럼프 대통령은 제약 회사들에게 제조를 미국으로 되돌려 놓지 않으면 관세에 직면할 것이라는 엄중한 경고를 했다고 보도되었다. 금요일(21일) 블룸버그 통신에 따르면 트럼프 대통령은 비공개 회의에서 제약사들에 임박한 관세에 대해 경고하며 해외 생산을 미국으로 서둘러 이전할 것을 촉구했다. 

트럼프, 거대 제약사에 경고 &#34;미국으로 생산 이전 안 하면 관세 부과&#34;

PHARMARON BEIJING CO LTD by PHARMARON BEIJING CO LTD.

Pharmaron Beijing Co Ltd

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares are volatile Monday after the company announced it will deploy <a href="https://www.benzinga.com/markets/equities/25/01/43295163/elon-musk-says-unsupervised-full-self-driving-begins-as-tesla-can-now-drive-itself-from-factory-to-loading-docks">full self-driving features in China</a>.
What To Know: According to a Bloomberg<a href="https://www.bloomberg.com/news/articles/2025-02-24/tesla-prepares-to-deploy-long-awaited-fsd-features-in-china?embedded-checkout=true"> report</a>, Tesla is preparing a software update for Tesla owners in China that will allow vehicles to offer driver-assistance capabilities similar to what&#8217;s being marketed as full self-driving in the United States.
The report indicates that the planned update is expected to be rolled out in the coming days. According to a person familiar with the matter, the new features will allow Tesla owners to use the assisted driving features on city streets. 
Some of the capabilities reportedly include guiding vehicles through intersections, recognizing traffic signals, making turns, changing lanes and adjusting speeds. Although the capabilities are marketed as full self-driving (FSD), the report indicates that the system still requires constant human supervision.
Check This Out: <a href="https://www.benzinga.com/tech/25/02/43908919/tesla-to-launch-refreshed-model-s-x-later-this-year-says-senior-exec">Tesla To Launch Refreshed Model S, X Later This Year, Says Senior Exec</a>
Tesla has reportedly drafted the language for the software update, which includes cautions related to the timing and effectiveness of some features. A person familiar with the matter said city street driving features will initially be available on certain models as the company works to expand the offering gradually. 
Tesla owners in China will be able to access the full self-driving features for 64,000 yuan ($8,800). 
TSLA Price Action: <a href="http://benzinga.com/quote/tsla">Tesla shares</a> initially traded up to around $346 in early trading Monday, before pulling back with the broader market. The stock was down 0.93% at $334.68 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: courtesy of Tesla.

Global

Movers

TSLA

What's Going On With Tesla Stock Monday?

Tempus AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) shares are moving higher on Monday. The company may be moving higher ahead of its 2024 fiscal-year fourth-quarter earnings report, which is scheduled to be released after <a href="https://www.benzinga.com//node/43916956">the market closes</a>.
What To Know: Analysts estimate a loss per share of 20 cents and revenue of $203.12 million, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>. 
In its preliminary earnings report for the quarter, the company guided revenue of about $200 million. It also expects the trend of sequential improvement in adjusted EBITDA to continue.
&#8220;We concluded 2024 with continued strength in our core businesses, as genomics revenue is expected to grow at ~30%&nbsp;in&nbsp;Q4&nbsp;and our data and services revenue is expected to grow at ~45%, such that we expect to deliver ~99%&nbsp;of our revenue&nbsp;guidance&nbsp;for 2024 and ~100%&nbsp;of our adjusted EBITDA&nbsp;guidance,&#8221; said Eric Lefkofsky, Founder and CEO of Tempus. 
&#8220;Despite some softness in our CRO revenues, our core businesses gained momentum throughout the year.&#8221;
For the 2024 fiscal year third quarter, the company reported a loss of 25 cents per share, missing analysts&#8217; estimate of a loss of 21 cents. In addition, Tempus reported revenue of $180.93 million, missing analysts&#8217; estimate of $207.82 million.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43921539/dollar-dips-as-fed-holds-line-but-jpmorgan-says-floor-is-near">Dollar Dips As Fed Holds Line, But JPMorgan Says Floor Is Near</a>
TEM Price Action: At the time of writing, Tempus stock is trading 3.76% higher at $70.67, per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Tempus

What's Going On With Tempus AI Shares Monday?

Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) stock is moving higher on Monday after the company announced <a href="https://www.sec.gov/Archives/edgar/data/1713210/000149315225007977/ex99-1.htm">it signed</a> an irrevocable corporate purchase order with Swiss One Oil and Gas.
What To Know: The purchase order is for approximately 200,000 metric tons of EN590 10 ppm diesel and 2,000,000 barrels of Jet Fuel AI1. Furthermore, the two companies entered into a strategic partnership to enhance oil and gas sales and purchase operations.
The partnership between Agape ATP and Swiss One centers on resource sharing to enhance supply chain operations and logistics. In addition, both companies plan to integrate advanced technologies to improve operational efficiency, such as inventory management, order processing, and real-time shipment tracking.
The partnership also includes a commitment to sustainability, with both companies working to reduce their carbon footprint. The companies will prioritize the adoption of environmentally responsible practices across their operations.
&#8220;This partnership is a major step forward in ATPC&#8217;s diversification strategy, reinforcing our role in the global energy sector. By working with Swiss One, we are not only optimizing oil and gas procurement but also driving innovation, efficiency and sustainability within the supply chain,&#8221; said Prof Dato&#8217; Sri Dr How Kok Choong, founder and Global Group CEO of ATPC.
See Also: <a href="https://www.benzinga.com/25/02/43919364/ai-meets-data-salesforce-google-collaborate-to-revolutionize-autonomous-business-agents">Salesforce &amp; Google Supercharge AI: New Partnership Unlocks Next-Gen Business Automation</a>
ATPC Price Action: At the time of publication, ATPC stock is trading 50.6% higher at $1.41, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

ATPC

What's Going On With Agape ATP Shares Monday?

<a href="https://www.benzinga.com/etfs">Defiance ETFs</a> filed for approval of the MAGA Seven ETF (MAGT) with the U.S. Securities and Exchange Commission (SEC), according to a report by ETF.com.
What Happened: The fund aims to build a portfolio of just seven stocks that, according to Defiance, "appear positioned to benefit from the economic, regulatory, and policy environment shaped by the Trump administration and its potential future impact."
The name MAGT is a play on the Magnificent 7, the tech stocks that have led the market's rally over the past few years. But unlike the traditional tech-heavy lineup, MAGT's holdings will be actively selected and equally weighted, according to etf.com. Companies can be swapped in and out based on their alignment with Trump-era or future policies.
Also Read: <a href="https://www.benzinga.com/markets/25/02/43906811/trump-reportedly-warns-big-pharma-move-manufacturing-to-us-or-face-tariffs">Trump Reportedly Warns Big Pharma &#8211; Move Manufacturing To US Or Face Tariffs</a>
One of Trump's first executive actions in his second term was rolling back regulations on artificial intelligence (AI), aiming to "clear a path for the United States to act decisively to retain global leadership in artificial intelligence." This move is expected to fuel rapid advancements in AI innovation and development, creating investment opportunities in AI-focused stocks and ETFs.
Trump also <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43128141/tech-stocks-rise-after-trump-announces-ai-infrastructure-investment">announced a $500 billion AI infrastructure initiative</a> in January, called Stargate. Initial funding for the initiative will come from SoftBank, OpenAI, Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), and UAE-based MGX. 
Given this backdrop, AI-focused stocks and ETFs could be among the biggest beneficiaries of Trump's second term.
Why It Matters: The concentrated nature of MAGT's portfolio could mean big wins or big losses. 
"Depending on the stocks, you could really have a nice run, but the concentration could also lead to underperformance," said Eric Balchunas, senior ETF analyst at Bloomberg Intelligence, per the ETF.com report.
MAGT is directly tied to Trump's policy impact on businesses.
Under the Biden administration, antitrust measures targeted big players like Google (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), and Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>). Trump, however, has indicated a more lenient stance, signaling that Big Tech may face fewer regulatory hurdles under his administration.
Trump is likely to <a href="https://www.techtarget.com/searchcio/news/366615993/Google-breakup-likely-off-the-table-under-Trump">continue </a>several antitrust cases against major tech companies, he also expressed skepticism about breaking them up. In October, he questioned whether dismantling Google would harm the company too severely. This shift in regulatory stance could further position tech stocks favorably under Trump's leadership.
What&#8217;s Next: While MAGT's exact holdings remain unknown, Balchunas speculates that stocks like Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), and Amazon could be included, per ETF.com. These names have already performed well under Trump's presidency and could see further gains if policies shift in their favor.
Investors should keep in mind that while politics shape policies, markets have a mind of their own.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43918590/wall-street-retreats-as-inflation-worries-mount-5-etfs-that-stood-strong-last-week">Wall Street Retreats As Inflation Worries Mount, 5 ETFs That Stood Strong Last Week</a></li>
</ul>
Photo: Shutterstock

New ETFs

ETFs

AAPL

AMZN

COIN

GOOGL

ORCL

Defiance Seeks SEC Approval For ETF Tied To Trump Policies: 'You Could Have A Nice Run, But...'

JD.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) shares are trading lower by 7% to $39.49 during Monday's session, retreating after recent gains. The stock has gained 15% on a year-to-date basis, benefiting from a broader rally in Chinese equities and following Alibaba's <a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43888574/alibabas-ai-expansion-e-commerce-growth-reinforce-bullish-analyst-outlook">strong earnings report</a> last week. 
Investor confidence in China's economic recovery and the tech sector has driven renewed interest in Chinese growth stocks in 2025, including JD.com.
What To Know: As one of China's largest e-commerce companies, JD.com operates an extensive logistics network and a highly integrated supply chain, distinguishing itself from competitors with its focus on direct sales and reliable delivery services.
Read Also: <a href="https://www.benzinga.com/news/25/02/43915797/why-nikola-nkla-stock-is-getting-hammered">Why Nikola Stock Is Getting Hammered</a>
Alibaba's earnings report, which signaled a resurgence in <a href="https://www.benzinga.com/markets/asia/25/02/43761193/xi-jinping-and-jack-mas-upcoming-meeting-a-clear-message-of-beijings-support-stock-soars-in-hong-kong-ahead-of-earnings">Chinese consumer spending</a>, bodes well for JD.com's business model. A stronger retail environment could boost demand for JD's core e-commerce platform, as well as its growing cloud computing and logistics segments.
What Else: Investor sentiment has also improved amid increased government support for private enterprises and technological innovation. With reduced regulatory pressure on Chinese companies listed in the U.S., JD.com stands to benefit from a more favorable operating environment.
Additionally, renewed foreign capital inflows into Chinese equities have played a role in JD.com's recent uptrend. Two major Chinese tech firms recently <a href="https://www.benzinga.com/25/02/43884588/alibaba-leads-china-stock-rally-as-deepseeks-ai-breakthrough-and-xis-support-boost-investor-confidence">raised $500 million</a> through offshore equity sales, further signaling growing confidence in China's growth prospects.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/02/43916521/whats-going-on-with-atlasclear-holdings-stock-monday">What&#8217;s Going On With AtlasClear Holdings Stock Monday?</a>
Investors can gain exposure to JD.com by investing in the KraneShares CSI China Internet ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NASDAQ">KWEB</a>) or iShares China Large-Cap ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NASDAQ">FXI</a>).
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, JD has a 52-week high of $47.82 and a 52-week low of $21.18.

KWEB

What's Going On With JD.com Stock?

Financial giants have made a conspicuous bearish move on United Rentals. Our analysis of options history for United Rentals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>) revealed 16 unusual trades.
Delving into the details, we found 25% of traders were bullish, while 56% showed bearish tendencies. Out of all the trades we spotted, 12 were puts, with a value of $645,741, and 4 were calls, valued at $171,922.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $520.0 to $780.0 for United Rentals over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for United Rentals options trades today is 81.09 with a total volume of 152.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for United Rentals's big money trades within a strike price range of $520.0 to $780.0 over the last 30 days.
<h3>United Rentals 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740424535_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>URI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$64.4</td>
<td>$60.3</td>
<td>$62.35</td>
<td>$700.00</td>
<td>$80.7K</td>
<td align="right">203</td>
<td align="right">14</td>
</tr>
<tr>
<td>URI</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$146.5</td>
<td>$138.5</td>
<td>$141.9</td>
<td>$780.00</td>
<td>$70.9K</td>
<td align="right">61</td>
<td align="right">0</td>
</tr>
<tr>
<td>URI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$30.2</td>
<td>$28.1</td>
<td>$28.9</td>
<td>$650.00</td>
<td>$69.3K</td>
<td align="right">180</td>
<td align="right">3</td>
</tr>
<tr>
<td>URI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$50.2</td>
<td>$48.1</td>
<td>$48.25</td>
<td>$640.00</td>
<td>$62.7K</td>
<td align="right">25</td>
<td align="right">12</td>
</tr>
<tr>
<td>URI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$8.2</td>
<td>$8.1</td>
<td>$8.2</td>
<td>$610.00</td>
<td>$60.6K</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About United Rentals</h3>
United Rentals is the world's largest equipment rental company. It principally operates in the United States and Canada, where it commands approximately 15% share in a highly fragmented market. It serves three end markets: general industrial, commercial construction, and residential construction. Like its peers, United Rentals historically has provided its customers with equipment that was intermittently used, such as aerial equipment and portable generators. As the company has grown organically and through hundreds of acquisitions since it went public in 1997, its catalog (fleet size of $22 billion) now includes a range of specialty equipment and other items that can be rented for indefinite periods.
Following our analysis of the options activities associated with United Rentals, we pivot to a closer look at the company's own performance.
<h3>Current Position of United Rentals</h3>
<ul>
<li>With a trading volume of 576,050, the price of URI is up by 0.18%, reaching $658.5.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 58 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for United Rentals</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $923.75.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for United Rentals, targeting a price of $1000. 
&#x2A; An analyst from Evercore ISI Group has decided to maintain their Outperform rating on United Rentals, which currently sits at a price target of $974. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on United Rentals with a target price of $765. 
&#x2A; An analyst from Truist Securities downgraded its action to Buy with a price target of $956. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest United Rentals options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

This Is What Whales Are Betting On United Rentals

Whales with a lot of money to spend have taken a noticeably bullish stance on Robinhood Markets.
Looking at options history for Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) we detected 77 trades.
If we consider the specifics of each trade, it is accurate to state that 49% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 20 are puts, for a total amount of $1,604,296 and 57, calls, for a total amount of $3,434,552.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $26.0 to $80.0 for Robinhood Markets over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Robinhood Markets's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Robinhood Markets's whale trades within a strike price range from $26.0 to $80.0 in the last 30 days. 
<h3>Robinhood Markets Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740424530_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/14/25</td>
<td>$3.05</td>
<td>$3.0</td>
<td>$3.05</td>
<td>$50.00</td>
<td>$305.1K</td>
<td>153</td>
<td>591</td>
</tr>
<tr>
<td>HOOD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$24.45</td>
<td>$23.95</td>
<td>$24.15</td>
<td>$65.00</td>
<td>$241.5K</td>
<td>157</td>
<td>200</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$25.4</td>
<td>$25.05</td>
<td>$25.3</td>
<td>$26.00</td>
<td>$202.4K</td>
<td>1.9K</td>
<td>80</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$18.35</td>
<td>$18.1</td>
<td>$18.3</td>
<td>$50.00</td>
<td>$183.0K</td>
<td>5.7K</td>
<td>3.2K</td>
</tr>
<tr>
<td>HOOD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$1.68</td>
<td>$1.61</td>
<td>$1.62</td>
<td>$32.00</td>
<td>$170.5K</td>
<td>258</td>
<td>8</td>
</tr>
</tbody>
</table>

<h3>About Robinhood Markets</h3>
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.
After a thorough review of the options trading surrounding Robinhood Markets, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Robinhood Markets Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 30,603,102, the HOOD's price is down by -1.38%, now at $50.89. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 72 days.</li>
</ul>
<h3>What The Experts Say On Robinhood Markets</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $72.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Keefe, Bruyette &amp; Woods persists with their Market Perform rating on Robinhood Markets, maintaining a target price of $60. 
&#x2A; An analyst from Keybanc has decided to maintain their Overweight rating on Robinhood Markets, which currently sits at a price target of $75. 
&#x2A; An analyst from JMP Securities persists with their Market Outperform rating on Robinhood Markets, maintaining a target price of $77. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Robinhood Markets with a target price of $75. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Robinhood Markets with a target price of $76. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Robinhood Markets, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

HOOD

Robinhood Markets Options Trading: A Deep Dive into Market Sentiment

Financial giants have made a conspicuous bullish move on Hims &amp; Hers Health. Our analysis of options history for Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) revealed 83 unusual trades.
Delving into the details, we found 49% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 47 were puts, with a value of $4,713,116, and 36 were calls, valued at $3,336,186.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $25.0 to $72.0 for Hims &amp; Hers Health over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Hims &amp; Hers Health's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hims &amp; Hers Health's whale activity within a strike price range from $25.0 to $72.0 in the last 30 days. 
<h3>Hims &amp; Hers Health Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740424525_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$4.95</td>
<td>$4.35</td>
<td>$4.55</td>
<td>$46.00</td>
<td>$910.0K</td>
<td>353</td>
<td>4.0K</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/28/25</td>
<td>$14.1</td>
<td>$13.8</td>
<td>$14.1</td>
<td>$61.00</td>
<td>$705.0K</td>
<td>3.0K</td>
<td>3.5K</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$5.2</td>
<td>$5.15</td>
<td>$5.15</td>
<td>$47.50</td>
<td>$426.6K</td>
<td>39</td>
<td>409</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.4</td>
<td>$3.15</td>
<td>$3.15</td>
<td>$60.00</td>
<td>$422.8K</td>
<td>2.2K</td>
<td>2.5K</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$5.4</td>
<td>$5.2</td>
<td>$5.2</td>
<td>$50.00</td>
<td>$396.8K</td>
<td>6.2K</td>
<td>3.4K</td>
</tr>
</tbody>
</table>

<h3>About Hims &amp; Hers Health</h3>
Hims &amp; Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
After a thorough review of the options trading surrounding Hims &amp; Hers Health, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Hims &amp; Hers Health Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 35,327,577, with HIMS's price up by 6.73%, positioned at $52.6.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 0 days.</li>
</ul>
<h3>Professional Analyst Ratings for Hims &amp; Hers Health</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $49.67.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Underperform rating for Hims &amp; Hers Health, targeting a price of $21. 
&#x2A; In a cautious move, an analyst from Morgan Stanley downgraded its rating to Equal-Weight, setting a price target of $60. 
&#x2A; An analyst from Canaccord Genuity has decided to maintain their Buy rating on Hims &amp; Hers Health, which currently sits at a price target of $68. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Hims &amp; Hers Health options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Smart Money Is Betting Big In HIMS Options

WIIM

AEON

AEON Biopharma shares are trading lower after the company announced a 1-for-72 reverse stock split.

Needham analyst Mike Cikos reiterated a Hold rating on the shares of DigitalOcean Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCN#NYSE">DOCN</a>).
The analyst has a favorable outlook on DigitalOcean ahead of its earnings report, as the analyst notes the increased pace of product development under CEO Paddy Srinivasan will lead to stronger growth among Scalers &amp; Builders, while improving customer retention before they transition to Hyperscalers.
Net Dollar Retention is expected to stay below 100%, but the comparison will become easier as the analyst anniversary Cloudways price gains in April.
Management has projected fourth-quarter revenue to reach between $199.0 million and $201.0 million, reflecting a year-over-year growth of 10.0%-11.1%.
The sell-side model anticipates a 10.9% increase, reaching $200.6 million, which is at the upper end of the guidance range and slightly above the analyst&#8217;s forecast of $200.2 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43911212/tiktok-collaboration-powers-connexas-new-mena-strategy-stocks-skyrocket" rel="noreferrer noopener">TikTok Collaboration Powers Connexa&#8217;s New MENA Strategy</a>
The analyst expects DigitalOcean to surpass both the upper limit of the guidance and the consensus estimate, in line with the company&#8217;s history of exceeding expectations by an average of 1.3% over the past four quarters.
DigitalOcean&#8217;s Net Dollar Retention (NDR) has remained at 97% for the past three quarters due to challenging year-over-year comparisons related to Cloudways&#8217; price hike, which the company will lap in April.
The core DigitalOcean business is performing better than the reported NDR, a positive sign for pushing NDR above 100% in the future.
DigitalOcean has significantly adjusted its strategy to better engage Builders and Scalers, which made up 88% of its revenue in the latest quarter.
Recent product updates, such as Virtual Private Cloud (VPC) peering and Global Load Balancers, are designed to better serve these customers. The analyst notes DigitalOcean is carefully balancing the need to retain Builders and Scalers on its platform before they transition to a Hyperscaler.
The analyst anticipates that DigitalOcean will offer a more comprehensive update on customer demand, the progress of commitments, and its overall approach to AI/ML products, especially within the Platform and SaaS layers.
Price Action: DOCN shares are trading lower by 7.05% at $36.53 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43917692/starbucks-lays-off-1100-corporate-employees-in-major-restructuring" target="_blank" rel="noreferrer noopener">Starbucks Lays Off 1,100 Corporate Employees In Major Restructuring</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Equities

Price Target

Reiteration

Analyst Ratings

Trading Ideas

General

DOCN

What To Expect From DigitalOcean Q4 Earnings?

BitMEX Research has criticized <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43590115/trump-meme-coin-left-a-sour-taste-in-traders-mouths-10x-research">Donald Trump's meme coin launch</a> as a stark example of political corruption enabled by blockchain technology, arguing it reflects decades of eroded trust in U.S. leadership.
What Happened: In a blog <a href="https://blog.bitmex.com/trumps-memecoin-political-corruption-on-the-blockchain-pages/">post</a> published on Monday, the research arm of the cryptocurrency exchange dissected how Trump, as President, leveraged his position to profit from Official Trump (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>), a speculative digital asset, raising questions about legality and political accountability.
The report draws on commentator Demetri Kofinas' view that Trump's actions undermine the presidency's integrity. 
"You're President of the United States&#8230; and you're launching a meme coin!" Kofinas said, calling the Jan. 20, inauguration-day launch "a gut punch" to Trump's national rejuvenation platform.
BitMEX Research frames this as a culmination of systemic failures, citing past scandals like Hunter Biden's Burisma role and the 2008 financial crisis as precursors that normalized such behavior.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43919492/gaia-co-founder-identifies-centralized-models-data-access-as-key-roadblocks-to-decentralized-ai-shift">Gaia Co-Founder Identifies Centralized Models, Data Access As Key Roadblocks To Decentralized AI Shift &#8211; Benzinga</a>
Why It Matters: Contrastingly, Maelstrom Chief Investment Officer Arthur Hayes offers a defense, suggesting meme coins could revolutionize political funding.
"This is much better than how the Bidens feathered their nest through a raft of secret payoffs from foreign businesses," Hayes said, proposing that transparent corruption via meme coins outshines opaque traditional grafts. 
Yet, BitMEX Research remains skeptical, warning that Trump's allocation of 80% of TRUMP tokens to himself exemplifies greed-driven absurdity within an already tarnished crypto ecosystem.
The blog also notes broader cynicism about Western values, with Grant Williams linking meme coins to a "moral vacuum" fueled by speculative bubbles. 
BitMEX Research states that while Trump's strategy may energize supporters, it risks economic productivity by diverting capital into speculative ventures rather than substantive growth.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43914267/sec-drops-investigation-into-robinhoods-crypto-unit">SEC Drops Investigation Into Robinhood&#8217;s Crypto Unit</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$TRUMP

Trump Meme Coin Was 'A Gut Punch', BitMex Research Says

AEON Biopharma Shares Halted On Circuit Breaker To The Downside, Stock Now Down -43.9%

<a href="https://www.marijuanamoment.net/senator-john-fetterman-circulates-petition-to-legalize-marijuana-at-the-federal-level/" title="https://www.marijuanamoment.net/senator-john-fetterman-circulates-petition-to-legalize-marijuana-at-the-federal-level/">https://www.marijuanamoment.net/senator-john-fetterman-circulates-petition-to-legalize-marijuana-at-the-federal-level/</a>

Biotech

AKAN

CRON

GRWG

IMCC

LFLY

MAPS

MSOS

SNDL

TLRY

'Senator John Fetterman Circulates Petition To Legalize Marijuana At The Federal Level' - Marijuana Moment

U.S. stocks were mixed, with the Dow Jones falling over 200 points on Monday.
Shares of Bridge Investment Group Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRDG#NASDAQ">BRDG</a>) rose sharply during Monday's session after Apollo Global Management announced that it will acquire the company in a $1.5 billion <a href="https://www.benzinga.com/quote/BRDG/news">all-stock transactio</a>n.
Bridge Investment Group shares surged 35.2% to $10.71 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Diginex Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) shares jumped 32% to $66.00.</li>
<li>Telix Pharmaceuticals Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLX#NASDAQ">TLX</a>) gained 20.7% to $23.53 after the company reported better-than-expected quarterly financial results.</li>
<li>Canada Goose Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOOS#NYSE">GOOS</a>) rose 11.8% to $11.65.</li>
<li>Freshpet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) gained 9.4% to $109.68 after Jefferies upgraded the stock from Hold to Buy.</li>
<li>Sun Communities, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>) climbed 7.2% to $135.17 after the company announced that it has entered into a definitive agreement to sell 100% of its interests in the Safe Harbor Marinas business to affiliates of Blackstone Infrastructure.</li>
<li>Zeta Global Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) gained 6.8% to $22.14.</li>
<li>Reinsurance Group of America, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) rose 6.5% to $201.79 after the company announced a reinsurance transaction with Equitable Holdings.</li>
</ul>
Read This Next:<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43909562/top-2-industrials-stocks-that-are-set-to-fly-this-quarter"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43909562/top-2-industrials-stocks-that-are-set-to-fly-this-quarter">Top 2 Industrials Stocks That Are Set To Fly This Quarter</a></li>
</ul>

Pre-Market Outlook

BRDG

DGNX

FRPT

GOOS

ZETA

Bridge Investment Group, Telix Pharmaceuticals, Sun Communities, And Other Big Stocks Moving Higher On Monday

<a href="https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_02242025_SNGX_Bautz.pdf" title="https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_02242025_SNGX_Bautz.pdf">https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_02242025_SNGX_Bautz.pdf</a>

SNGX

Watching Soligenix; Zacks Small-Cap Research Gives Stock $35 Price Valuation

AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) (the "Company"), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today announced that the Company's Board of Directors approved a 1-for-72 reverse stock split (the "Reverse Stock Split") of the Company's common stock, par value $0.0001 (the "Common Stock"), to increase the selling price of the Company's Common Stock in order to maintain compliance with the requirements and policies of the NYSE American LLC (the "NYSE American").
The Reverse Stock Split will take legal effect at 12:01 A.M. Eastern Time on February 26, 2025, and the Company's Common Stock will open for trading on the NYSE American on February 26, 2025, on a post-split basis, under the existing ticker symbol "AEON" but with a new CUSIP number [00791X 209].

Stock Split

AEON Biopharma Announces 1-For-72 Reverse Stock Split

Legendary investor Warren Buffett released the latest Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>)(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) shareholder letter over the weekend.
The <a href="https://www.benzinga.com/trading-ideas/25/02/43893285/warren-buffetts-annual-shareholder-letter-arrives-saturday-could-investors-get-updates-on-apple-succession-new-investments">highly anticipated release </a>included many updates and comments on the state of the market and the company's businesses, but one missing item could become a big topic of discussion.
What Happened: Berkshire Hathaway's <a href="https://www.benzinga.com/25/02/43900955/berkshire-hathaways-q4-profits-soar-71-warren-buffett-says-his-firm-has-paid-more-taxes-than-tech-titans-in-trillions">newest shareholder letter </a>highlighted the company's different business segments, including the strength of the insurance sector.
Across Berkshire Hathaway there are 189 operating businesses, which collectively employ nearly 400,000 people.
As part of Berkshire Hathaway&#8217;s annual report, the letter omitted a line on the company's diversity that had been in past shareholder letters, as <a href="https://nypost.com/2025/02/23/business/buffetts-berkshire-hathaway-removes-diversity-and-inclusion-from-annual-report/">reported </a>by the New York Post.
The previous report said Berkshire Hathaway's hiring practices "intended to identify qualified candidates and promote diversity and inclusion in the workforce."
This year's letter stopped that line after the word candidates, omitting the diversity and inclusion line.
Berkshire Hathaway did not respond to a request for comment by Benzinga at the time of writing.
In May 2024, Berkshire Hathaway shareholders voted down a proposal for the company to disclose more about its efforts to promote DEI. The company's board of directors opposed the proposal.
You may not be a billionaire like Warren Buffett, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/trading-ideas/25/02/43900861/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-54">check out five stocks flying under the radar that deserve your attention.</a>
 Why It's Important: The removal of the diversity and inclusion line could be Berkshire Hathaway following many other companies that have changed their hiring policies and wording to omit terms like diversity and inclusion in the current Donald Trump White House administration era.
Trump has fought to eliminate DEI, a common acronym for diversity, equity and inclusion, across businesses and federal government agencies. DEI is often used by companies to promote fair hiring policies to also include people who are underrepresented in the workforce and are more likely to be discriminated against in the hiring process.
Another explanation could be Berkshire Hathaway giving the power to their operating units to decide what is best for their own hiring processes. This could be a way to not be targeted by Trump and also let its businesses hire based on their own terms.
One of Berkshire Hathaway's largest portfolio companies has <a href="https://www.benzinga.com/news/25/02/43737860/coca-cola-pepsico-adjust-dei-policies-following-trump-executive-order-report">changed its DEI programs</a> and hiring practices. Beverage giant Coca-Cola Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) was expected to revise its DEI policy to adhere to a new White House mandate that affects beverage services on military bases and other government properties.
The beverage company recently said that its cooperation with DEI mandates for federal contractors<a href="https://www.benzinga.com/25/02/43881721/coca-cola-warns-shortage-of-diverse-talent-could-harm-future-success"> could hurt </a>the company's business.
"If we are unable to attract or retain specialized talent or top talent with diverse perspectives, experiences and backgrounds that reflect the broad range of consumers and markets we serve around the world, our business could be negatively affected," Coca-Cola said in its recent risk factors of a financial filing.
Berkshire Hathaway owns 400 million Coca-Cola shares, representing around 9.3% of the beverage company.
Changing DEI policies and wording on websites and in materials is becoming more common for companies in the Trump era.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/25/01/42832123/warren-buffett-beats-sp-500-in-2024-how-oracle-of-omahas-returns-compare-over-past-20-years">Warren Buffett Beats S&amp;P 500 In 2024, How Oracle Of Omaha&#8217;s Returns Compare Over Past 20 Years</a></li>
</ul>
Photo: Buffett, Courtesy of the White House/Public Domain; Berkshire Hathaway, Shutterstock

Warren Buffett Backtracks On DEI? Berkshire Hathaway Shareholder Letter Removes Diversity Mention

In the preceding three months, 6 analysts have released ratings for EPAM Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAM#NYSE">EPAM</a>), presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $274.0, a high estimate of $295.00, and a low estimate of $250.00. This upward trend is apparent, with the current average reflecting a 5.38% increase from the previous average price target of $260.00.
<img src="https://www.benzinga.com/files/images/story/2025/1740423662_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of EPAM Sys among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Divya Goyal</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$250.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$265.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$256.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Surinder Thind</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$288.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Ramsey El-Assal</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$290.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>James Schneider</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$295.00</td>
<td>$235.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to EPAM Sys. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of EPAM Sys compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of EPAM Sys's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of EPAM Sys's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EPAM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on EPAM Sys analyst ratings.</a>
<h2>Delving into EPAM Sys's Background</h2>
EPAM Systems is a global IT services firm that offers platform engineering, software development, and consulting services. EPAM's largest market is North America, which represents approximately 60% of revenue. Offerings span assisting companies with new technologies, such as artificial intelligence, virtual reality, and robotics.
<h3>Financial Milestones: EPAM Sys's Journey</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, EPAM Sys showcased positive performance, achieving a revenue growth rate of 6.92% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: EPAM Sys's net margin excels beyond industry benchmarks, reaching 8.27%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): EPAM Sys's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.88%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): EPAM Sys's ROA stands out, surpassing industry averages. With an impressive ROA of 2.24%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.04.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EPAM

Analyst Expectations For EPAM Sys's Future

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Allegro Microsystems and provided 12-month price targets. The average target is $28.0, accompanied by a high estimate of $30.00 and a low estimate of $23.00. Witnessing a positive shift, the current average has risen by 8.53% from the previous average price target of $25.80.
<img src="https://www.benzinga.com/files/images/story/2025/1740423653_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Allegro Microsystems among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Quinn Bolton</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Joseph Moore</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$23.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Quinn Bolton</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Blayne Curtis</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$30.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Joseph Quatrochi</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$27.00</td>
<td>$23.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Allegro Microsystems. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Allegro Microsystems compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Allegro Microsystems's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ALGM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Allegro Microsystems analyst ratings.</a>
<h2>Discovering Allegro Microsystems: A Closer Look</h2>
Allegro Microsystems Inc is a designer, developer, fabless manufacturer, and marketer of sensor ICs and application-specific analog power ICs for automotive and industrial markets. Its Sensor IC allows customers to precisely measure motion, speed, position, and current, and Power ICs include high-temperature and high-voltage capable motor drivers, power management, and LED driver ICs. Its products are divided into three categories such as SENSE which includes Current Sensors, Switches and Latches, and Interface ICs among others; REGULATE which includes Regulators, ClearPower Modules, and LED Drivers; and DRIVE which includes BLDC Drivers, Brush DC, and others. Key revenue for the company is generated from Greater China and the rest from the United States, Japan, Europe, and other regions.
<h3>Allegro Microsystems's Financial Performance</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Negative Revenue Trend: Examining Allegro Microsystems's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -30.24% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -3.86%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Allegro Microsystems's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -0.73%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.47%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Allegro Microsystems's debt-to-equity ratio stands notably higher than the industry average, reaching 0.43. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Significance of Analyst Ratings Explained</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALGM

What Analysts Are Saying About Allegro Microsystems Stock

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Consolidated Edison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Consolidated Edison and provided 12-month price targets. The average target is $96.6, accompanied by a high estimate of $101.00 and a low estimate of $92.00. This upward trend is evident, with the current average reflecting a 2.11% increase from the previous average price target of $94.60.
<img src="https://www.benzinga.com/files/images/story/2025/1740423647_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Consolidated Edison among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Weisel</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$101.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Nicholas Campanella</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$95.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Anthony Crowdell</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$95.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Nicholas Campanella</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$92.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Andrew Weisel</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$100.00</td>
<td>$90.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Consolidated Edison. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Consolidated Edison compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Consolidated Edison's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Consolidated Edison's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ED/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Consolidated Edison analyst ratings.</a>
<h2>Delving into Consolidated Edison's Background</h2>
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange &amp; Rockland, or O&amp;R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities generate nearly all of Con Ed's earnings following the sale of its clean energy business to RWE in early 2023.
<h3>Consolidated Edison's Financial Performance</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Consolidated Edison's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 6.53%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Utilities sector.
Net Margin: Consolidated Edison's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 8.45%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Consolidated Edison's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.41%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Consolidated Edison's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.45%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Consolidated Edison's debt-to-equity ratio is below the industry average. With a ratio of 1.27, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Consolidated Edison Stock: Analyst Perspectives (5 Ratings)

Pharmaron Beijing Co

도널드 트럼프 대통령은 제약 회사들에게 제조를 미국으로 되돌려 놓지 않으면 관세에 직면할 것이라는 엄중한 경고를 했다고 보도되었다.
무슨 일 있었나: 금요일(21일) <a href="https://www.bloomberg.com/news/articles/2025-02-21/trump-told-drugmakers-to-move-production-to-us-or-face-tariffs">블룸버그</a> 통신에 따르면 트럼프 대통령은 비공개 회의에서 제약사들에 임박한 관세에 대해 경고하며 해외 생산을 미국으로 서둘러 이전할 것을 촉구했다.
목요일(20일)에는 일라이 릴리(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) CEO인 데이비드 릭스(David Ricks), 머크(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) CEO인 로버트 데이비스(Robert Davis), 화이자(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) CEO인 앨버트 불라(Albert Bourla), 제약 산업 최대 로비 단체의 수장인 스티븐 유블(Stephen Ubl)이 백악관에서 트럼프와 만났다. 이들 경여진은 트럼프에게 연방 정부가 특정 의약품 가격을 협상할 수 있는 법안을 제한하는 노력을 지지해줄 것을 설득하고, 환자 부담 비용을 증가시키는 중개인에 대한 대책을 지지해줄 것을 요청했다.
블룸버그 보도에 따르면, 트럼프는 제약 업계가 요구해 온 조 바이든 전 대통령 재임 시절에 제정된 약가 프로그램 완화를 위해 의회를 지지하겠다고 약속하지는 않았다.
메디케어 관계자는 금요일에 약가 협상 프로그램의 다음 단계가 예정되어 있으며 노보 노디스크(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>)의 블록버스터 체중 감량 약물인 오젬픽과 웨고비가 포함될 것이라고 확인했다.
한편, 트럼프 대통령은 로버트 F. 케네디 주니어 보건복지부 장관과 그의 메디케어 및 메디케이드 서비스센터장 지명자인 메멧 오즈(Mehmet Oz)가 약가 인하를 위해 노력하고 있다고 밝혔다.
왜 중요한가: 지난주 트럼프는 미국으로 수입되는 의약품에 <a href="https://www.benzinga.com/25/02/43805852/trump-shakes-global-trade-with-25-auto-chip-and-pharma-tariffs-announcement-asian-stocks-pare-their-five-day-rally">25%의 관세를 부과</a>할 것을 제안했다. 트럼프의 이러한 최근 움직임은 제약 업계와의 이전 대립을 고려할 때 놀라운 일이 아니다. 첫 임기 동안 그는 한때 제약업계가 약값으로 &#8216;살인&#8217;하고 있다고 비난하기도 했다.
ING 은행은 미국이 2024년에 약 36%의 의약품을 수입할 것으로 추정하며, 아일랜드, 독일, 스위스가 주요 수입국으로 꼽힌다. 한편, 대서양위원회의 데이터에 따르면 미국의 중국산 의약품 수입은 2020~2022년 사이에 485% 급증한 것으로 나타났다.
최근 트럼프 대통령이 제약회사에 미국 내 생산 전환을 경고한 이후, 중국 바이오테크 주가는 오늘 아시아 거래에서 큰 타격을 입었다. 우시 바이로직스(OTC:<a class="ticker" href="https://www.benzinga.com/stock/WXXWY#OTC">WXXWY</a>), WuXi AppTec우시 앱텍(OTC:<a class="ticker" href="https://www.benzinga.com/stock/WUXAY#OTC">WUXAY</a>), 파마론 베이징(OTC:<a class="ticker" href="https://www.benzinga.com/stock/PHBBF#OTC">PHBBF</a>) 주가가 크게 하락했다.
그러나 ING는 바이든 행정부의 보고서에 따르면 용량 제한이 의약품 부족의 원인이라고 지적했기 때문에 미국 제약 제조를 확대하라는 트럼프의 요구가 정당하다고 주장했다. 하지만 워싱턴대학교의 2022년 보고서에 따르면 용량 확장에는 2~3년이 소요될 것이다.
이미지 출처: Shutterstock
면책 조항: 이 콘텐츠는 부분적으로 AI 도구의 도움을 받아 생성되었으며, Benzinga 편집자가 검토하고 게시했습니다.
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Pharmaron Beijing Co

뉴스

에 대한 최신 뉴스 Pharmaron Beijing Co (OTC:PHBBF) 주식

월요일, 2월 24, 2025

뉴스

파트너 / 기고자

벤징가 글로벌